ConforMIS Stock News

Shares of Conformis (CFMS) are down 5% in after-hours trading after the companys Q4 2021 results missed on the top and bottom lines.

ConforMIS press release (CFMS): Q4 GAAP EPS of -$0.09 misses by $0.02.Revenue of $15.4M (-7.8% Y/Y) misses by $0.21M.

BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today

BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2021.

Conformis, Inc.'s (CFMS) CEO Mark Augusti on Q4 2021 Results - Earnings Call Transcript

Orthopedic devices company Conformis (CFMS) said it is suspending deliveries of its products as well as business development in Russia. The company recently entered into a…

ConforMIS (NASDAQ:CFMS) is scheduled to announce Q4 earnings results on Wednesday, March 2nd, after market close.The consensus EPS Estimate is -$0.07 (+12.5% Y/Y) and the consensus…

BILLERICA, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), the pioneer and leader of fully personalized orthopedic medical devices, today announced results of a published retrospective study of patients showing the superiority of Conformis'' implants in several key measures of clinical success and patient satisfaction. According to the study published in The Journal of Bone & Joint Surgery Reviews (JBJS Reviews) 1 , patients who had undergone bilateral total knee arthroplasty (TKA) preferred their Conformis fully personalized knee compared to their bilateral off-the-shelf knee at a rate of more than 10 to 1. The study surveyed 47 TKA patients who had a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant in their other knee. The study found that 72.3 percent of the patients studied preferred their fully personalized Conformis knee replacement, compared to 6.4 percent of patients who preferred their traditional off-the-shelf (OTS) implant.

Conformis, Inc. (NASDAQ:CFMS) with the stream of 1.66% also noticed, India Almaden Minerals Ltd. (AMEX:AAU) encountered a rapid change of -3.00% in the last hour of trading session. Conformis, Inc. … The post Hot Stock to Observe: Conformis, Inc. (NASDAQ:CFMS), Almaden Minerals Ltd. (AMEX:AAU) appeared first on Stocks Equity .

BILLERICA, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today th

BILLERICA, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that

CFMS, JD, and PZG have been added to the Zacks Rank #5 (Strong Sell) List on February 14, 2022

CFMS, JD, and PZG have been added to the Zacks Rank #5 (Strong Sell) List on February 14, 2022

In last trading session, Conformis Inc. (NASDAQ:CFMS) saw 0.61 million shares changing hands with its beta currently measuring 1.41. Company’s recent per share price level of $0.63 trading at $0.05 or 9.33% at ring of the bell on the day assigns it a market valuation of $116.05M. That closing price of CFMS’s stock is at … Conformis Inc. (NASDAQ:CFMS) Gained 12.53% In A Week: What’s Driving The Stock? Read More »